Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shannon A Carty

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 2, 2022
The physical exam's role in determining dose-limiting toxicity prior to immunochemotherapy administration in lymphomaJohn S Runge, Anna B Brown, Tycel J Phillips, et al.
Case Reports in Gastrointestinal Medicine|November 7, 2025
Simultaneous Presentation of Post-Transplant Lymphoproliferative Disorder (PTLD) and Acute Cellular Rejection (ACR) in a Liver Transplant Recipient: A Therapeutic ConundrumAnkit Mishra, Matthew Kubina, Dhiraj K Peddu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 20, 2014
Development of innate CD4+ and CD8+ T cells in Itk-deficient mice is regulated by distinct pathwaysAmanda L Prince, Zachary Kraus, Shannon A Carty, et al.
Leukemia & Lymphoma|November 16, 2020
Clinical application of next generation sequencing in lymphomaAnthony J Scott, Molly C Tokaz, Maryann Shango, et al.
Leukemia & Lymphoma|June 9, 2025
Cost effectiveness of mosunetuzumab and CAR-T cell therapy in relapsed/refractory follicular lymphomaMeng-Hsuan Lin, Jonathan Weiss, Tycel J Phillips, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 19, 2017
The Loss of TET2 Promotes CD8<sup>+</sup> T Cell Memory DifferentiationShannon A Carty, Mercy Gohil, Lauren B Banks, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2011
Requirements for eomesodermin and promyelocytic leukemia zinc finger in the development of innate-like CD8+ T cellsScott M Gordon, Shannon A Carty, Jiyeon S Kim, et al.
Blood Advances|April 4, 2023
Adding venetoclax to lenalidomide and rituximab is safe and effective in patients with untreated mantle cell lymphomaTycel J Phillips, David Bond, Radihka Takiar, et al.
Communications Biology|July 2, 2026
Choline-dependent methionine metabolism supports leukemia progressionNirmalya Saha, Lauren Lachowski, Franchesca Franzen, et al.
Leukemia|July 1, 2021
Germline POT1 variants can predispose to myeloid and lymphoid neoplasmsTristan L Lim, David B Lieberman, Adam R Davis, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 2, 2022
The physical exam's role in determining dose-limiting toxicity prior to immunochemotherapy administration in lymphomaJohn S Runge, Anna B Brown, Tycel J Phillips, et al.
Case Reports in Gastrointestinal Medicine|November 7, 2025
Simultaneous Presentation of Post-Transplant Lymphoproliferative Disorder (PTLD) and Acute Cellular Rejection (ACR) in a Liver Transplant Recipient: A Therapeutic ConundrumAnkit Mishra, Matthew Kubina, Dhiraj K Peddu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 20, 2014
Development of innate CD4+ and CD8+ T cells in Itk-deficient mice is regulated by distinct pathwaysAmanda L Prince, Zachary Kraus, Shannon A Carty, et al.
Leukemia & Lymphoma|November 16, 2020
Clinical application of next generation sequencing in lymphomaAnthony J Scott, Molly C Tokaz, Maryann Shango, et al.
Leukemia & Lymphoma|June 9, 2025
Cost effectiveness of mosunetuzumab and CAR-T cell therapy in relapsed/refractory follicular lymphomaMeng-Hsuan Lin, Jonathan Weiss, Tycel J Phillips, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 19, 2017
The Loss of TET2 Promotes CD8<sup>+</sup> T Cell Memory DifferentiationShannon A Carty, Mercy Gohil, Lauren B Banks, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2011
Requirements for eomesodermin and promyelocytic leukemia zinc finger in the development of innate-like CD8+ T cellsScott M Gordon, Shannon A Carty, Jiyeon S Kim, et al.
Blood Advances|April 4, 2023
Adding venetoclax to lenalidomide and rituximab is safe and effective in patients with untreated mantle cell lymphomaTycel J Phillips, David Bond, Radihka Takiar, et al.
Communications Biology|July 2, 2026
Choline-dependent methionine metabolism supports leukemia progressionNirmalya Saha, Lauren Lachowski, Franchesca Franzen, et al.
Leukemia|July 1, 2021
Germline POT1 variants can predispose to myeloid and lymphoid neoplasmsTristan L Lim, David B Lieberman, Adam R Davis, et al.
Pageof 3